Verve Therapeutics, Inc. (VERV)
Jul 25, 2025 - VERV was delisted (reason: acquired by LLY)
11.13
0.00 (0.00%)
Inactive · Last trade price on Jul 24, 2025
Chimerix Employees
Verve Therapeutics had 274 employees as of December 31, 2024. The number of employees increased by 19 or 7.45% compared to the previous year.
Employees
274
Change (1Y)
19
Growth (1Y)
7.45%
Revenue / Employee
$217,566
Profits / Employee
-$660,606
Market Cap
994.14M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 274 | 19 | 7.45% |
| Dec 31, 2023 | 255 | 51 | 25.00% |
| Dec 31, 2022 | 204 | 91 | 80.53% |
| Dec 31, 2021 | 113 | - | - |
VERV News
- 7 days ago - Lilly completes acquisition of Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk - PRNewsWire
- 8 days ago - Lilly and Verve announce expiration of Verve tender offer - PRNewsWire
- 6 weeks ago - VERVE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verve Therapeutics, Inc. - VERV - Business Wire
- 6 weeks ago - Top 3 Health Care Stocks That Are Ticking Portfolio Bombs - Benzinga
- 6 weeks ago - Eli Lilly to Acquire Verve Therapeutics for Up to $1.3 Billion - WSJ
- 6 weeks ago - Eli Lilly to acquire gene-editing therapy developer Verve Therapeutics for up to $1.3 billion, companies say - Reuters
- 6 weeks ago - Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk - PRNewsWire
- 6 weeks ago - Eli Lilly Close to $1.3 Billion Bid for Biotech, Says Report. Verve Therapeutics Stock Soars 80%. - Barrons